Health

  • May 13, 2026

    CMS To Keep $1.3B From Calif., Halt New Hospice Enrollment

    The federal government on Wednesday announced it will defer more than $1.3 billion in Medicaid funds from California and halt new Medicare enrollments for hospices and home health agencies, saying it was part of an effort to crack down on fraudulent activity.

  • May 13, 2026

    3 NJ Employers Accused Of Pregnancy Discrimination

    A New Jersey hospital system, a laboratory company and a cleaning business must answer to allegations that they engaged in pregnancy discrimination in the workplace, state enforcers said this week.

  • May 13, 2026

    Walgreens Investors' Opioid Suit Is Time-Barred, Judge Says

    Pharmacy giant Walgreens no longer faces a proposed class action alleging it hurt investors when it disclosed opioid-related litigation losses after a Chicago federal judge found the claims were time-barred.

  • May 13, 2026

    Washington Hits Providence Health With Pregnancy Bias Suit

    Washington slapped Providence Health & Services with a lawsuit Wednesday claiming the health system routinely rejected accommodation requests from pregnant employees, denying them spaces to pump breast milk, seating and schedule flexibility to attend doctor appointments.

  • May 13, 2026

    Bayer, Buyers Get Final OK Of $4.85M Benzene Settlement

    A New Jersey federal judge on Wednesday gave final approval to a $4.85 million settlement to end claims against Bayer Healthcare LLC and others alleging that antifungal products were contaminated with benzene.

  • May 13, 2026

    DOJ Fraud Division Set To Shake Up White-Collar Enforcement

    President Donald Trump's administration created the U.S. Department of Justice's National Fraud Enforcement Division with a narrow focus on combating government program fraud, but a move to retain federal prosecutors focused on other types of fraud could signal a wider scope with potential ripple effects across white-collar enforcement.

  • May 13, 2026

    Becton Hernia Mesh Antitrust Case Survives Dismissal

    A Pennsylvania federal court has refused to toss an antitrust case from Tela Bio Inc. accusing Becton Dickinson & Co. of abusing its dominant position in the hernia mesh market to block competing products.

  • May 13, 2026

    Provider Says NY Is On The Hook For $3.3M Medicaid Shortfall

    The New York State Department of Health's refusal to enforce payment obligations by Medicaid managed care organizations has cost a Queens-based safety net provider at least $3.3 million in underpayments for behavioral health services, according to a suit filed in New York federal court.

  • May 13, 2026

    Conn. Doctor Asked To Pay $880K In IVF Fraud Dispute

    Two people who accused a reproductive endocrinologist of using his own sperm to impregnate their mothers have proposed that the doctor settle their suit against him for a total of $880,000, according to separate offers filed in Connecticut state court.

  • May 13, 2026

    Crowell & Moring Opens Minneapolis Office With 8 Lawyers

    Crowell & Moring LLP announced Wednesday that it is deepening its commitment to Minnesota by opening a new office in Minneapolis with a team of eight attorneys and said it's expecting more growth in the near future.

  • May 12, 2026

    ​​​​​​​Amazon Beats Sanctions Bid Over Supplement Product Pages

    A Washington federal judge declined to sanction Amazon for allegedly failing to preserve product pages for dietary supplements that shoppers claim were improperly labeled, ruling that the retail giant fulfilled its duty to retain the information despite storing it as lines of code instead of viewable documents.

  • May 12, 2026

    Cigna Says HIPAA Doesn't Save Website Privacy Suit

    A proposed group of Cigna health plan participants can't cite HIPAA to keep up their claims that the insurer improperly tracked their private information through its websites, since the privacy law doesn't cover the kind of information the company collected, the insurer told a Pennsylvania federal court.

  • May 12, 2026

    Attys For Tufts Profs Didn't Blink In A Tenure Standoff

    When Jennifer Henricks and Kevin Peters first learned what was happening to tenured professors at Tufts University School of Medicine in Boston a few years ago, they knew that what was at stake involved more than just a dispute over the terms of a contract.

  • May 12, 2026

    DOJ Playing 'Dirty Pool' With Hospital In Trans Care Subpoena

    A Rhode Island federal judge indicated Tuesday she's likely to quash a subpoena from the U.S. Department of Justice seeking to obtain gender-affirming care medical records from Rhode Island Hospital, saying the DOJ was playing "dirty pool" by filing a motion to enforce the subpoena in another jurisdiction.

  • May 12, 2026

    White & Case Seeks Contempt In Modivcare Ch. 11 Fee Spat

    White & Case said Modivcare Inc. should be held in contempt for not moving $1.6 million to a Texas bankruptcy court escrow, intensifying a fight over fees the law firm racked up representing unsecured creditors in the reorganized healthcare services group's Chapter 11.

  • May 12, 2026

    AliveCor Wants Apple Health Monitor Patent Claims Tossed

    A medical software company has told a California federal court that claims in a pair of health monitoring patents Apple has accused it of infringing are actually invalid, saying they only cover abstract ideas without a technological innovation to save them.

  • May 12, 2026

    Drone Co. Skirts Unfair Biz Practices Claim In Ex-VP's Pay Suit

    North Carolina's Business Court pared down a dispute between a company that makes emergency response drones and its former vice president of sales, finding his claim that the company misled him about its intent to pay him a bonus doesn't rise to the level of an unfair or deceptive business practice.

  • May 12, 2026

    Texas AG Targets CVS DEI Program, Threatens Fraud Probe

    Texas Attorney General Ken Paxton on Tuesday warned CVS Health its diversity, equity and inclusion program for suppliers may violate state and federal antidiscrimination laws and gave the company 14 days to respond or risk a Medicaid fraud investigation.

  • May 12, 2026

    Commerce Details Path To Discount For 100% Pharma Tariff

    The U.S. Department of Commerce released guidance for pharmaceutical companies looking to show they have made sufficient onshoring commitments to qualify for a discount on the 100% tariff on certain imported drugs coming this summer.

  • May 12, 2026

    6th Circ. Says Jailers Entitled To Immunity In Detainee Death

    The Sixth Circuit has ruled that a group of jail officials in Michigan should be given qualified immunity from a lawsuit alleging they ignored the medical needs of a man who was incarcerated in their facility and later died from cardiac arrest.

  • May 12, 2026

    Nurse's Family Fights Workers' Comp Loss Over COVID Death

    The family of a North Carolina nurse who died from COVID-19 is challenging the denial of their workers' compensation claim, saying the state incorrectly determined she most likely contracted the virus in the community despite federal standards indicating healthcare workers faced an increased risk of exposure at work.

  • May 12, 2026

    Fox Rothschild Adds Trial Partner From Nelson Mullins In Fla.

    Fox Rothschild LLP has expanded its litigation department in West Palm Beach, Florida, with a new partner from Nelson Mullins Riley & Scarborough LLP.

  • May 12, 2026

    Mass. Appeals Court Tosses Convictions For Assault On Police

    A Massachusetts man who was convicted of assaulting police officers was not criminally responsible because the state hadn't shown he wasn't insane, an appeals court majority said Tuesday.

  • May 12, 2026

    Pa. Panel Struggles With Oversight Of $2.2B Opioid Fund

    A Pennsylvania appellate court on Tuesday questioned the system for distributing opioid companies' settlement money, after three counties and the city of Philadelphia said a review board unfairly disapproved their projects after the money was spent.

  • May 12, 2026

    Makary Out As FDA Commissioner, Trump Says

    U.S. Food and Drug Administration Commissioner Marty Makary is departing the agency, President Donald Trump confirmed on Tuesday, bringing to an end a tumultuous, one-year run as one of the nation's top health officials.

Expert Analysis

  • Series

    Law School's Missed Lessons: How To Draft Pleadings

    Author Photo

    Most law school graduates step into their first jobs without ever having drafted a complaint, answer, motion or other type of pleading, but that gap can be closed by understanding the strategy embedded in every filing, writing with clarity and purpose, and seeking feedback at every step, says Eric Yakaitis at Haug Barron.

  • E-Discovery Quarterly: Recent Rulings On ESI Control

    Author Photo

    Several recent federal court decisions have perpetuated a split over what constitutes “control” of electronically stored information — with judges divided on whether the standard should turn on a party's legal right or practical ability to obtain the information, say attorneys at Sidley.

  • The Challenge Of Stabilizing Rural Hospitals On The Brink

    Author Photo

    The outlook for rural hospitals has grown more concerning, as recent policy and regulatory developments are decreasing hospital revenues and increasing the cost of uncompensated care, which may result in additional hospital closures, service reductions, or mergers and acquisitions, say Omur Celmanbet, Kristy Piccinini and Sabiha Quddus at FTI Consulting.

  • Insurer Lessons From 1st Wave Of GenAI Coverage Rulings

    Author Photo

    Several pending cases target the issue of whether generative AI may appropriately replace human professional decision-making, and though each case is still in discovery, the decisions thus far provide insurers with guidance on how courts may view these claims, say attorneys at Simpson Thacher.

  • The Role Of Operational Data In Tech Platform Liability Suits

    Author Photo

    As litigation becomes a de facto substitute for the regulation of major technology platforms, with plaintiffs advancing claims under product liability, public nuisance and consumer protection laws, among others, courts are evaluating how platform systems operate in practice based on large-scale operational data, say attorneys at Brattle.

  • 2 Discovery Rulings Break With Heppner On AI Privilege Issue

    Author Photo

    While a New York federal court’s recent ruling in U.S. v. Heppner suggests that some litigants’ communications with AI tools are discoverable, two other recent federal court decisions demonstrate that such interactions generally qualify for work-product protection under the Federal Rules of Civil Procedure, says Joshua Dunn at Brown Rudnick.

  • Bid Protest Spotlight: Evidence, Tailored Talks, Materiality

    Author Photo

    In this month's bid protest roundup, Brian Doll at MoFo delves into three recent decisions from the Government Accountability Office about the evidentiary standards necessary to sustain a protest, discussions tailored to individual proposals, and misrepresentation claims involving factors irrelevant to the agency's decision.

  • Series

    Isshin-Ryu Karate Makes Me A Better Lawyer

    Author Photo

    My involvement in martial arts, specifically Isshin-ryu, which has principles rooted in the eight codes of karate, has been one of the most foundational in the development of my personality, and particularly my approach to challenges — including in my practice of law, says Kaitlyn Stone at Barnes & Thornburg.

  • Class Actions At The Circuit Courts: April Lessons

    Author Photo

    In this month's review of class action appeals, Mitchell Engel at Shook Hardy identifies practice tips from three recent rulings involving allegations of racial discrimination in mortgage applications, health insurance networks and actual cash value losses.

  • Fraud Enforcement, Sentencing Face Unusual Convergence

    Author Photo

    The Trump administration’s newly created task force to eliminate fraud and the U.S. Sentencing Commission’s recent proposals to scale back certain elements of the federal sentencing framework seem to point in opposite directions, creating a collision of policy priorities that may reshape how fraud cases are charged, negotiated and sentenced for years to come, says David Tarras at Tarras Defense.

  • Peptide Policy Is Shifting Toward Sanctioned Compounding

    Author Photo

    The policy landscape for peptides is undergoing a significant shift under the Trump administration, moving toward a complex system of verified compounding and complementary enforcement that will likely bring peptides firmly back into the sphere of legitimate consumer products, say attorneys at Sheppard.

  • Keys To Building Defensible Psychedelic Therapy Programs

    Author Photo

    Given the rapidly evolving legal environment for psychedelic therapies and heightened liability and compliance risks facing providers, meticulous documentation, robust risk management protocols, and proactive engagement with professional organizations and insurers are essential strategies, say Kimberly Chew at Husch Blackwell and L. Alison McInnes at Mindful Health Solutions.

  • Opinion

    State Bars Need To Get Specific About AI Confidentiality

    Author Photo

    Lawyers need to put actual client information into artificial intelligence tools to get their full value, but they cannot confidently do so until state bars offer clear, formal authority on which plan tiers of the three most popular generative AI tools are safe to use when sharing specific client details, says attorney Nick Berk.

  • Trump Order Signals Tougher Benefits Fraud Probes

    Author Photo

    A recent order from President Donald Trump establishing a federal taskforce for addressing fraud in federally funded benefit programs emphasizes interagency information sharing, potentially affecting a broad range of areas including government contracts, administrative law considerations and False Claims Act cases, say attorneys at Morgan Lewis.

  • Opinion

    Judicial Restraint Anchors Constitutional Order

    Author Photo

    Contrasting opinions in two recent U.S. Supreme Court rulings — Trump v. CASA and Bost v. Illinois State Board of Elections — demonstrate how the judiciary’s constitutionally entrusted role can easily be preserved or disrupted, and invite renewed attention to the enduring importance of judicial restraint, says Ninth Circuit Judge J. Clifford Wallace.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.